These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 21764497

  • 1. [Risk factor treatment and control in relation to coronary disease risk in the Spanish population of the DARIOS Study].
    Baena-Díez JM, Félix FJ, Grau M, Cabrera de León A, Sanz H, Leal M, Elosua R, Rodríguez-Pérez Mdel C, Guembe MJ, Torán P, Vega-Alonso T, Ortiz H, Pérez-Castán JF, Frontera-Juan G, Lapetra J, Tormo MJ, Segura A, Fernández-Bergés D, Marrugat J.
    Rev Esp Cardiol; 2011 Sep; 64(9):766-73. PubMed ID: 21764497
    [Abstract] [Full Text] [Related]

  • 2. [Quality of life in patients with risk factors of coronary heart disease].
    Kwaśniewska M, Drygas W.
    Przegl Lek; 2005 Sep; 62(9):863-70. PubMed ID: 16541719
    [Abstract] [Full Text] [Related]

  • 3. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K, Pesek T, Rados M, Buković D, Fures R, Cuk V.
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [Abstract] [Full Text] [Related]

  • 4. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000 Sep; 74(3):215-53. PubMed ID: 10918811
    [Abstract] [Full Text] [Related]

  • 5. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event.
    Dallongevillle J, De Bacquer D, Heidrich J, De Backer G, Prugger C, Kotseva K, Montaye M, Amouyel P, EUROASPIRE Study Group.
    Heart; 2010 Nov; 96(21):1744-9. PubMed ID: 20956490
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
    McNicoll S, Latour Y, Rondeau C, Bouthillier D, Davignon J, Genest J.
    Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of conventional risk factors in Jordanians with coronary heart disease: the Jordan Hyperlipidemia and Related Targets Study (JoHARTS).
    Hammoudeh AJ, Al-Tarawneh H, Elharassis A, Haddad J, Mahadeen Z, Badran N, Izraiq M, Al-Mousa E.
    Int J Cardiol; 2006 Jun 16; 110(2):179-83. PubMed ID: 16233922
    [Abstract] [Full Text] [Related]

  • 8. Metabolic syndrome in Spain: prevalence and coronary risk associated with harmonized definition and WHO proposal. DARIOS study.
    Fernández-Bergés D, Cabrera de León A, Sanz H, Elosua R, Guembe MJ, Alzamora M, Vega-Alonso T, Félix-Redondo FJ, Ortiz-Marrón H, Rigo F, Lama C, Gavrila D, Segura-Fragoso A, Lozano L, Marrugat J.
    Rev Esp Cardiol (Engl Ed); 2012 Mar 16; 65(3):241-8. PubMed ID: 22305818
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Lipid distribution in the adult population of Catalonia].
    Plans P, Ruigómez J, Pardell H, Salleras L.
    Rev Clin Esp; 1993 Jun 16; 193(1):35-42. PubMed ID: 8337460
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study].
    Grau M, Elosua R, Cabrera de León A, Guembe MJ, Baena-Díez JM, Vega Alonso T, Javier Félix F, Zorrilla B, Rigo F, Lapetra J, Gavrila D, Segura A, Sanz H, Fernández-Bergés D, Fitó M, Marrugat J.
    Rev Esp Cardiol; 2011 Apr 16; 64(4):295-304. PubMed ID: 21397375
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Epidemiologic characteristics of major risk factors of coronary heart disease in residents from Beijing communities in different age groups].
    Wang JH, Hu DY, Fu YY, Sun YH, Wang GL, Guan F, Yu JM, Wang JS.
    Zhonghua Yi Xue Za Zhi; 2010 Mar 02; 90(8):529-34. PubMed ID: 20367964
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study.
    Nieto FJ, Alonso J, Chambless LE, Zhong M, Ceraso M, Romm FJ, Cooper L, Folsom AR, Szklo M.
    Arch Intern Med; 1995 Apr 10; 155(7):677-84. PubMed ID: 7695455
    [Abstract] [Full Text] [Related]

  • 20. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L, Shah A, Davies MJ, Rotonda J, Maccubbin D, Tribble D, Veltri E, Mitchel Y.
    Curr Med Res Opin; 2006 May 10; 22(5):823-35. PubMed ID: 16709304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.